Mireille G. Gillings

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

SENTÉ, Inc. provides skin care products. The firm's products include Daily Repair Complex, Neck Firming and Redness Control Complex creams. It offers dermal repair cream for people of various age groups and skin types for enhancing the skin tone, texture, elasticity, and overall appearance. The company serves customers through dermatologists and physicians in the United States. Sente was founded by Kleanthis G. Xanthopoulos and Marios Fotiadis in 2007 and is headquartered in Carlsbad, CA.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

MIR3, Inc. provides notification and response software solutions. It offers business continuity and disaster recovery, emergency notification, information technology alerting, business operations, and customer relationship management solutions. It serves financial, energy, healthcare, information technology, education, government, public safety, entertainment and hospitality, transportation and logistics, and manufacturing and supply chain industries. The company was founded in 1999 and is headquartered in San Diego, CA.

HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.

GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom.